跳至主要内容
临床试验/CTRI/2024/04/064992
CTRI/2024/04/064992尚未招募1 期

A randomised control study to evaluate the safety and efficacy of Levetiracetam in comparison to Magnesium Sulphate in the management of severe pre-eclampsia

BLDE(DU) Shri BM Patil medical College, Hospital and Resarch Center, Vijayapura0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Pregnant women with gestational age of more than or equal to 28 weeks presenting with features of severe pre-eclampsia and/ or imminent eclampsia, needing immediate delivery as per treating clinician’s decision
  • 2. No contraindication to either of the study drugs
  • 3.Patients giving written informed consent for investigations and the proposed intervention

排除标准

  • 1.Patients diagnosed with other causes of convulsions in pregnancy like cerebral malaria and epilepsy
  • 2.Pregnant women with chronic hypertension without super-imposed pre-eclampsia
  • 3.Pregnant females with fetal anomalies detected on USG
  • 4.Pregnant women who already have deranged renal parameters

研究者

发起方
BLDE(DU) Shri BM Patil medical College, Hospital and Resarch Center, Vijayapura

相似试验